Findings of a recent study indicate that NUP98 rearrangements can significantly impact outcomes in patients with acute myeloid leukemia (AML).

Mayo Clinic researchers have developed an innovative testing strategy for mesothelioma that could potentially increase the ...

Discovered in-house by Eisai’s Tsukuba Research Laboratories, TASFYGO is an orally available novel tyrosine kinase inhibitor ...

Mayo Clinic says this testing approach could help detect mesothelioma, a rare cancer that develops in the thin membranes that ...

Mayo Clinic researchers have developed an innovative testing strategy for mesothelioma that could potentially increase the detection rate of cancer DNA in the blood.